These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37861040)

  • 1. Raddeanin A Improves the Therapeutic Effect of Osimertinib in NSCLC by Accelerating ROS/NLRP3-mediated Pyroptosis.
    Lin L; Wu X; Jiang Y; Luo X; Cao X
    Curr Pharm Des; 2023; 29(32):2591-2600. PubMed ID: 37861040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reniformin A suppresses non-small cell lung cancer progression by inducing TLR4/NLRP3/caspase-1/GSDMD-dependent pyroptosis.
    Zhu H; Guan Y; Wang W; Liu X; Wang S; Zheng R; Li Y; Liu L; Huang H
    Int Immunopharmacol; 2024 May; 133():112068. PubMed ID: 38626545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huaier extract suppresses non-small cell lung cancer progression through activating NLRP3-dependent pyroptosis.
    Xie J; Zhuan B; Wang H; Wang Y; Wang X; Yuan Q; Yang Z
    Anat Rec (Hoboken); 2021 Feb; 304(2):291-301. PubMed ID: 31692261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis.
    Yuan R; Zhao W; Wang QQ; He J; Han S; Gao H; Feng Y; Yang S
    Pharmacol Res; 2021 Aug; 170():105748. PubMed ID: 34217831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer.
    Cai X; Miao J; Sun R; Wang S; Molina-Vila MA; Chaib I; Rosell R; Cao P
    Pharmacol Res; 2021 Aug; 170():105701. PubMed ID: 34087353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raddeanin A induced apoptosis of non-small cell lung cancer cells by promoting ROS-mediated STAT3 inactivation.
    Li L; Chen M; Li G; Cai R
    Tissue Cell; 2021 Aug; 71():101577. PubMed ID: 34146943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saikosaponin-D induces the pyroptosis of lung cancer by increasing ROS and activating the NF-κB/NLRP3/caspase-1/GSDMD pathway.
    Chen M; Hu C; Yang L; Guo Q; Liang Y; Wang W
    J Biochem Mol Toxicol; 2023 Aug; 37(8):e23444. PubMed ID: 37393521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial-mesenchymal transition.
    Liu K; Chen X; Wu L; Chen S; Fang N; Cai L; Jia J
    BMC Pulm Med; 2021 May; 21(1):163. PubMed ID: 33992097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation.
    Hayakawa D; Takahashi F; Mitsuishi Y; Tajima K; Hidayat M; Winardi W; Ihara H; Kanamori K; Matsumoto N; Asao T; Ko R; Shukuya T; Takamochi K; Hayashi T; Suehara Y; Takeda Nakamura I; Ueno T; Kohsaka S; Mano H; Takahashi K
    Thorac Cancer; 2020 Jan; 11(1):140-149. PubMed ID: 31758670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer.
    Chen W; Yu D; Sun SY; Li F
    Acta Biomater; 2021 Jul; 129():258-268. PubMed ID: 34048974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells.
    Wang RH; Chang CJ; Chen CH; Liu KK; Chao JI
    Anticancer Agents Med Chem; 2023; 23(11):1309-1319. PubMed ID: 36815658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Ephedra Herb extract on the expression of EGFR-activating mutations and c-Met in non-small-cell lung cancer cell line, H1975, and its combined effects with osimertinib.
    Mori E; Hyuga S; Hanawa T; Naoki K; Odaguchi H
    J Nat Med; 2023 Jun; 77(3):523-534. PubMed ID: 37043119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resibufogenin suppresses growth and metastasis through inducing caspase-1-dependent pyroptosis via ROS-mediated NF-κB suppression in non-small cell lung cancer.
    Yin H; Liu YG; Li F; Wang LQ; Zha JH; Xia YC; Yu BT; Wen DH
    Anat Rec (Hoboken); 2021 Feb; 304(2):302-312. PubMed ID: 32396707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpinumisoflavone suppresses hepatocellular carcinoma cell growth and metastasis via NLRP3 inflammasome-mediated pyroptosis.
    Zhang Y; Yang H; Sun M; He T; Liu Y; Yang X; Shi X; Liu X
    Pharmacol Rep; 2020 Oct; 72(5):1370-1382. PubMed ID: 32301055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sophflarine A, a novel matrine-derived alkaloid from Sophora flavescens with therapeutic potential for non-small cell lung cancer through ROS-mediated pyroptosis and autophagy.
    Luo D; Dai X; Tian H; Fan C; Xie H; Chen N; Wang J; Huang L; Wang H; Wang G; Zhang Y
    Phytomedicine; 2023 Jul; 116():154909. PubMed ID: 37269775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of quercetin on macrophage pyroptosis via TLR2/Myd88/NF-κB and ROS/AMPK pathway.
    Luo X; Bao X; Weng X; Bai X; Feng Y; Huang J; Liu S; Jia H; Yu B
    Life Sci; 2022 Feb; 291():120064. PubMed ID: 34688696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction.
    Lei Q; Yi T; Chen C
    Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TanshinoneIIA inhibits melanocyte pyroptosis by regulating the ROS/NLRP3 signaling axis.
    Li X; Tang S; Wang H; Li X
    Skin Res Technol; 2023 Sep; 29(9):e13419. PubMed ID: 37753685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine particulate matter exposure aggravates ischemic injury via NLRP3 inflammasome activation and pyroptosis.
    Gao L; Qin JX; Shi JQ; Jiang T; Wang F; Xie C; Gao Q; Zhi N; Dong Q; Guan YT
    CNS Neurosci Ther; 2022 Jul; 28(7):1045-1058. PubMed ID: 35403328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exon 16-Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M-Positive Non-Small Cell Lung Cancer.
    Hsu CC; Liao BC; Liao WY; Markovets A; Stetson D; Thress K; Yang JC
    J Thorac Oncol; 2020 Jan; 15(1):50-61. PubMed ID: 31557536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.